About My Health Careers Internship MedBlogs Contact us
C-Peptide Test Helps Diagnose and Treat Diabetes Accurately

C-Peptide Test Helps Diagnose and Treat Diabetes Accurately

Font : A-A+

  • C-peptide test can help in the accurate diagnosis and treatment of diabetes
  • This simple and cheap test can differentiate between Type-1 and Type-2 diabetes, as well as other subtypes
  • Correct diagnosis of the subtype of diabetes can help to adjust treatments based on the results of the C-peptide test

C-peptide levels in the blood or urine can indicate how much insulin is being produced and therefore, can be used as a simple and cheap test to diagnose the type of diabetes that a patient has. This can help doctors to change the medications accordingly. A team of researchers at the University of Exeter Medical School, UK have developed one such test, which is being presented at the Diabetes UK Professional Conference 2019 at the Arena and Convention Center (ACC), Liverpool, UK.

C-Peptide and its Role in Diagnosis of Diabetes

C-peptide, also known as a connecting peptide, is a short 31-amino acid polypeptide that connects insulin's A-chain with its B-chain in the proinsulin molecule. A C-peptide test is used to differentiate between Type-1 and Type-2 diabetes. In Type-1 diabetes, very little or no insulin is produced, and so, the corresponding C-peptide level is also very low. In Type-2 diabetes, however, an ample amount of insulin is produced, and therefore, the level of C-peptide is much more elevated and higher than normal values. This difference in the levels of C-peptide helps to diagnose and differentiate between Type-1 and Type-2 diabetes more accurately.


C-Peptide Test Helps Diagnose and Treat Diabetes Accurately

The C-Peptide Test Developed by the University of Exeter, UK

A team of researchers at the University of Exeter Medical School, UK have developed a simple and inexpensive test for measuring the levels of C-peptide in the blood or urine, which can show what kind of treatment will be most effective in diabetic patients. The test has been evaluated by clinicians at the Western General Hospital in Edinburgh, Scotland in over 750 patients, clinically diagnosed as having Type-1 diabetes for over three years.

The C-peptide test results revealed that these patients were not actually Type-1 diabetics and therefore, the insulin therapy could be stopped and oral tablets could be given instead. In fact, Type-2 diabetes was clinically misdiagnosed as Type-1 diabetes in 28 patients and in 12 patients; it was actually possible to stop the insulin therapy.

In this regard, Dr. Angus Jones, from the University of Exeter Medical School, says: "It can be highly challenging for clinicians to differentiate between Type-1 and Type-2, and a number of genetic subtypes of diabetes. Up to 15 percent of insulin treated patients are misdiagnosed. This figure soars to 40 percent of people developing Type-1 diabetes after age 30, as identifying Type-1 diabetes at this age is very difficult. Treatment for these is very different, which is why being able to confirm if a person has the right diagnosis is so important. For example, people with Type-1 diabetes need lifelong insulin injections and become very unwell without this treatment, but most people with Type-2 and genetic subtypes of diabetes can be effectively treated with tablets. By measuring C-peptide in a person receiving insulin treatment, we can make sure they have the right diagnosis, and therefore the best treatment for them."

Salient Features of the New C-Peptide Test

  • It is simple, robust and cheap - costing just £10 per test
  • It has an impact on deciding the correct treatment, patient education and follow-up care
  • It can reveal if there is a genetic cause behind diabetes, which impacts treatment as well as establishing whether there is a family history of the disease. A genetic cause has been confirmed in 8 patients
  • Measuring C-peptide levels can tell how much insulin is being produced de novo within the body, even if the patient is taking insulin injections
  • The test is available in Edinburgh and Glasgow under the National Health Service (NHS) for testing patients with Type-1 diabetes for at least three years

Study Findings

  • Optimal storage conditions for the blood and urine samples were established, making sample collection and storage easier
  • A specific preservative was identified that allowed blood C-peptide samples to be stored for over 24 hours
  • The above findings permit C-peptide testing to be used in routine clinical care in outpatient clinics
  • Blood and urine C-peptide testing can identify the correct subtype of diabetes
  • C-peptide is a cheap and effective test for diagnosing a genetic form of diabetes, which otherwise requires expensive tests
  • Clinical studies show that C-peptide can predict the efficacy of specific antidiabetic drugs in individual patients
  • C-peptide can stratify response to a costly therapy in diabetics on insulin, thereby identifying patients unlikely to benefit from the therapy
  • Low C-peptide is associated with higher fluctuations in blood glucose, thereby increasing the risk of hypoglycemia in Type-2 diabetics on insulin

Expert Comments

Dr. Tim McDonald, of the University of Exeter Medical School, says: "Getting the right diagnosis in diabetes is absolutely key to achieving the best treatment outcomes and avoiding complications. We've shown that C-peptide is cheaper, more accurate and easier to use than previous methods. It's really gratifying to see this making a difference to improving patient health already. My lab alone has received 7,000 test samples in the past 12 months."

Dr. Emily Burns, who is Head of Research Communications at Diabetes UK, says: "Getting the right diagnosis of diabetes is so important; it means people will receive the right treatment for them and could avoid serious complications. But different forms of diabetes can be difficult to accurately diagnose. Researchers at the University of Exeter are leading the way in improving how we diagnose diabetes, and in making tests more widely available, to make sure as many people as possible can benefit."


The C-peptide test in Type-1 diabetes patients can improve diagnostic accuracy. It may even permit stopping of insulin therapy in some patients if the test results indicate Type-2 rather than Type-1 diabetes.

Reference :
  1. Measurement of C‐peptide in Patients with a Clinical Diagnosis of Type 1 Diabetes Improves Diagnostic Accuracy and May Allow Cessation of Insulin Therapy in Some Individuals [Abstract: A8 (P97)] - (https://doi.org/10.1111/dme.1_13882)

Source: Medindia

News A-Z
News Category
What's New on Medindia
Black Pepper as Preventive Measure Against Omicron
FODMAP Diet: A Beginner's Guide
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diabetic Retinopathy Diabetes Diabetic Diet Diabetes - Essentials Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Diabetes and Exercise Undescended Testicles Stress Relief Through Alternative Medicine Stress and the Gender Divide 

Recommended Reading
Clinical Trial Results Encourage Effort in Reversing Type 1 Diabetes
A phase I clinical trial has confirmed that use of a generic vaccine to raise levels of an immune .....
Less is More When It Comes to Controlling Weight and Blood Sugar Among Diabetics
A new study reveals that eating two large meals was better in controlling weight and blood sugar ......
Type 1 Diabetes: 'Seven Year Switch' Opens New Ways to Preserve Insulin Production
Quick decline in insulin production that causes type 1 diabetes continues to fall over seven years ....
Natriuretic Peptides in Adipose Tissue Protect Against Effects of High-Fat Diet
Boosting levels of NPs in adipose tissue may be an important avenue to explore for combating ......
A comprehensive article on diabetes - both Type 1 and Type 2 diabetes, including : causes, signs, sy...
Diabetes - Essentials
Diabetes is a metabolic disease caused by insulin deficiency that leads to high blood sugar levels a...
Diabetes - Self-Monitoring of Blood Glucose (SMBG)
Self-Monitoring Of Blood Glucose (SMBG) is one of the greatest advancements in the management of Di...
Diabetes and Exercise
Regular exercise especially in type II diabetes not only helps reduce the sugar but also reduces the...
Diabetic Diet
The diabetic diet most often recommended is high in dietary fiber (especially soluble fiber) and nut...
Diabetic Retinopathy
The term ‘diabetic retinopathy’ refers to changes in the retina which often occur in people with ......
Insulin Delivery Devices
Insulin delivery devices have evolved drastically since their invention in 1922. They are all aimed ...
Stress and the Gender Divide
Stress has become entwined in the current lifestyle of a young working couple and has resulted in th...
Undescended Testicles
An undescended testicle / testis is one that has not descended into the scrotal sac before birth. It...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use